AI Cocktail Night

​KIPalooza, Merantix Momentum, and frauwenk invite you to an evening event to discuss what real AI adoption looks like and the benefits of our incredible ecosystem. September 17, 2026
by

Subscribe to the Merantix Momentum Newsletter now.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

More articles

The latest industry news, interviews, technologies and resources.

Clyravision: An entire forensics team in one system

Clyravision: The intelligent forensics system that not only recognizes manipulated images, but also explains exactly how and why they were altered - for more transparency and trust in the digital world.

"AI in Market Access: Do We Have What It Takes?"

Interview with Menasheh Fogel - On AI in Market Access, Organizational Challenges, and the Future of Data-Driven Pricing and Reimbursement Strategies.

Transforming complex AI challenges into real impact: The intelligent healthcare system for the next decade

How AI, collaboration, and secure data infrastructures are redefining research, diagnostics, and care, paving the way for the intelligent healthcare system of the next decade.

From data chaos to breakthroughs

An expert interview with Dr. Stephan Hegge, VP of Corporate Strategy at HotSpot Therapeutics and Dr. Thomas Wollmann, CTO at Merantix Momentum

Addressing Challenges and Opportunities in Medical Writing Using AI

An interview with Dr. Richardus Vonk, Independent Advisor and Dr. Bertram Weiss, VP Health Vertical at Merantix Momentum.

AI Cocktail Night

Oops! Something has gone wrong.
Oops! Something has gone wrong.
Oops! Something has gone wrong.
Oops! Something has gone wrong.
Oops! Something has gone wrong.

Discover more whitepapers

The AI Canvas: Our tool for project evaluation

Discover the AI Canvas!

Leveraging the EU AI Act to your advantage

Using the EU AI Act to your advantage

Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.

Towards Tabular Foundation Models

About the status quo, challenges and opportunities

Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.

Artificial Intelligence for Private Equity Portfolios

Increase in value for your entire portfolio

Subscribe to the Merantix Momentum Newsletter now.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.